Cyclic guanosine monophosphate-enhancing reduces androgenic extracellular regulated protein kinases-phosphorylation/Rho kinase II-activation in benign prostate hyperplasia
Author:
Affiliation:
1. Graduate Institute of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan
2. Department of Pharmacology; College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.12195/fullpdf
Reference31 articles.
1. Study design of the medical therapy of prostatic symptoms (MTOPS) trial;Bautista;Control. Clin. Trials,2003
2. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck;Caine;Br. J. Urol.,1975
3. α1-adrenergic receptor subtypes in human detrusor;Malloy;J. Urol.,1998
4. alpha1-adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinas;Hu;J. Pharmacol. Exp. Ther.,1999
5. Alpha1 adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells. Role in mitogenesis;Hu;J. Biol. Chem.,1996
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Testosterone and Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Propensity Score-Matched Analysis;The Journal of Sexual Medicine;2016-07
2. Buffered l-ascorbic acid, alone or bound to KMUP-1 or sildenafil, reduces vascular endothelium growth factor and restores endothelium nitric oxide synthase in hypoxic pulmonary artery;The Kaohsiung Journal of Medical Sciences;2015-05
3. Insights into cardio-oncology: Polypharmacology of quinazoline-based α1-adrenoceptor antagonists;World Journal of Cardiology;2015
4. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model;The Kaohsiung Journal of Medical Sciences;2014-06
5. Rho kinase inhibitors: a patent review (2012 – 2013);Expert Opinion on Therapeutic Patents;2013-11-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3